Capstone Therapeutics Corp. 4
4 · Capstone Therapeutics Corp. · Filed Mar 1, 2013
Insider Transaction Report
Form 4
HOLLIMAN JOHN M III
DirectorExecutive Chairman
Transactions
- Award
Stock Option (Right to Buy)
2013-02-28+51,000→ 836,000 totalExercise: $0.21From: 2014-02-28Exp: 2023-02-28→ Common Stock (51,000 underlying)
Footnotes (1)
- [F1]50% to vest 2/28/13 and 50% to vest 2/28/14